Key result
Cardiovascular implantable electronic devices require comprehensive management including remote monitoring and novel technologies like smartwatches for atrial fibrillation screening to reduce complications.
Why the study?
Despite technological advances, clinical gaps remain in managing cardiovascular implantable electronic device patients, including long-term lead- and pocket-related complications and integrating remote monitoring and novel screening tools.
Answers are grounded in this paper and cite their sources.
This review highlights the evolving landscape of CIEDs, emphasizing the importance of remote monitoring and wearable technologies for arrhythmia screening while addressing the growing burden of device-related complications.
Cardiovascular implantable electronic devices (CIEDs) are essential management options for patients with brady- and tachyarrhythmias or heart failure with concomitant optimal pharmacotherapy. Despite increasing technological advances, there are still gaps in the management of CIED patients, eg, the growing number of lead- and pocket-related long-term complications, including cardiac device–related infective endocarditis, requires the greatest care. Likewise, patients with CIEDs should be monitored remotely as a part of a comprehensive, holistic management approach. In addition, novel technologies used in smartwatches may be a convenient tool for long-term atrial fibrillation (AF) screening, especially in high-risk populations. Early detection of AF may reduce the risk of stroke and other AF-related complications. The objective of this review article was to provide an overview of novel technologies in cardiac rhythm–management devices and future challenges related to CIEDs.
No takes yet. Share an insight, caveat, or question.
Kotalczyk et al. (2020) conducted a review in Brady- and tachyarrhythmias or heart failure. Cardiovascular implantable electronic devices (CIEDs) was evaluated. Cardiovascular implantable electronic devices require comprehensive management including remote monitoring and novel technologies like smartwatches for atrial fibrillation screening to reduce complications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: